Resultados da pesquisa - Michael Boyiadzis

Refinar resultados
  1. 1
    Plasma-derived exosomes in acute myeloid leukemia for detection of minimal residual disease: are we ready?

    Plasma-derived exosomes in acute myeloid leukemia for detection of minimal residual disease: are we ready? Por Michael Boyiadzis, Theresa L. Whiteside

    Publicado em 2016
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    Programmed death-1 checkpoint blockade in acute myeloid leukemia

    Programmed death-1 checkpoint blockade in acute myeloid leukemia Por Alison R. Sehgal, Theresa L. Whiteside, Michael Boyiadzis

    Publicado em 2015
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  3. 3
    Isolation and Characterization of CD34+ Blast-Derived Exosomes in Acute Myeloid Leukemia

    Isolation and Characterization of CD34+ Blast-Derived Exosomes in Acute Myeloid Leukemia Por Chang Sook Hong, Laurent Müller, Michael Boyiadzis, Theresa L. Whiteside

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia

    Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia Por Chang‐Sook Hong, Laurent Müller, Theresa L. Whiteside, Michael Boyiadzis

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor- 1

    Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor- 1 Por Mirosław J. Szczepański, Marta Szajnik, Anne Welsh, Theresa L. Whiteside, Michael Boyiadzis

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer

    Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer Por Chang‐Sook Hong, Sonja Funk, Laurent Müller, Michael Boyiadzis, Theresa L. Whiteside

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors

    Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors Por Mirosław J. Szczepański, Marta Szajnik, Ann Welsh, Kenneth A. Foon, Theresa L. Whiteside, Michael Boyiadzis

    Publicado em 2009
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease

    Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease Por Michael Boyiadzis, John M. Kirkwood, John L. Marshall, Colin C. Pritchard, Nilofer S. Azad, James L. Gulley

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  9. 9
    Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions

    Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology d... Por Peter H. Shaw, Michael Boyiadzis, Hussein Tawbi, Anne Welsh, Aimee Kemerer, Nancy E. Davidson, A. Kim Ritchey

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia

    You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia Por Alison R. Sehgal, Helmut König, D E Johnson, Daolin Tang, Ravi K. Amaravadi, Michael Boyiadzis, Michael T. Lotze

    Publicado em 2014
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  11. 11
    DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies

    DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies Por Annie Im, Alison R. Sehgal, Martin Carroll, B. Douglas Smith, Ayalew Tefferi, Daniel E. Johnson, Michael Boyiadzis

    Publicado em 2014
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  12. 12
    Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia

    Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia Por Chang‐Sook Hong, Priyanka Sharma, Saigopalakrishna S. Yerneni, Patricia Simms, Edwin K. Jackson, Theresa L. Whiteside, Michael Boyiadzis

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis

    Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis Por Kainat Saleem, Joseph Franz, Mary Lou Klem, Jonathan G. Yabes, Michael Boyiadzis, John R Jones, Nader Shaikh, Konstantinos Lontos

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  14. 14
    Triggering of Toll-like Receptor 4 Expressed on Human Head and Neck Squamous Cell Carcinoma Promotes Tumor Development and Protects the Tumor from Immune Attack

    Triggering of Toll-like Receptor 4 Expressed on Human Head and Neck Squamous Cell Carcinoma Promotes Tumor Development and Protects the Tumor from Immune Attack Por Mirosław J. Szczepański, Malgorzata Czystowska, Marta Szajnik, Malgorzata Harasymczuk, Michael Boyiadzis, A Kruk-Zagajewska, Witold Szyfter, J Zeromski, Theresa L. Whiteside

    Publicado em 2009
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia

    Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia Por Mirosław J. Szczepański, Marta Szajnik, Malgorzata Czystowska, Magis Mandapathil, Laura Strauss, Ann Welsh, Kenneth A. Foon, Theresa L. Whiteside, Michael Boyiadzis

    Publicado em 2009
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia

    Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia Por Kenneth A. Foon, Dhaval Mehta, Suzanne Lentzsch, Patricia Kropf, Stanley M. Marks, Diana Lenzner, L. Pietragallo, M. Sulecki, Ahmad A. Tarhini, Michael Boyiadzis

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Up-regulation of NK Cell Activating Receptors Following Allogeneic Hematopoietic Stem Cell Transplantation under a Lymphodepleting Reduced Intensity Regimen is Associated with Elevated IL-15 Levels

    Up-regulation of NK Cell Activating Receptors Following Allogeneic Hematopoietic Stem Cell Transplantation under a Lymphodepleting Reduced Intensity Regimen is Associated with Elev... Por Michael Boyiadzis, Sarfraz Memon, Jesse Carson, Kenton Allen, Mirosław J. Szczepański, Barbara A. Vance, Robert M. Dean, Michael Bishop, Ronald E. Gress, Frances T. Hakim

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation

    F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation Por Bill B. Chen, Jennifer R. Glasser, Tiffany A. Coon, Chunbin Zou, Hannah L. Miller, Moon J. Fenton, John F. McDyer, Michael Boyiadzis, Rama K. Mallampalli

    Publicado em 2012
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial

    Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial Por Terry Gernsheimer, Siobhan P. Brown, Darrell J. Triulzi, Nigel S. Key, Nahed El Kassar, Heather Herren, Jacqueline N. Poston, Michael Boyiadzis, Brandi Reeves, Subodh Selukar, Monica B. Pagano, Scott S. Emerson, Susanne May

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia

    Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia Por Kenneth A. Foon, Michael Boyiadzis, Stephanie R. Land, Stanley M. Marks, Anastasios Raptis, L. Pietragallo, Dennis Meisner, Andrew D. Laman, M. Sulecki, Allyson R. Butchko, P L Schaefer, Diana Lenzer, Ahmad A. Tarhini

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: